Calculating The Fair Value Of Colefax Group PLC (LON:CFX)
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:
We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model .
How far off is Colefax Group PLC ( LON:CFX ) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Story Continues
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.3%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 9.9%.
Terminal Value (TV)= FCF 2034 × (1 + g) ÷ (r – g) = UK£3.1m× (1 + 2.3%) ÷ (9.9%– 2.3%) = UK£41m
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= UK£41m÷ ( 1 + 9.9%)10= UK£16m
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is UK£41m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of UK£7.9, the company appears around fair value at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.
AIM:CFX Discounted Cash Flow May 6th 2025
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Colefax Group as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 9.9%, which is based on a levered beta of 1.473. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
See our latest analysis for Colefax Group
Next Steps:
Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Colefax Group, we've compiled three additional items you should explore:
Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Colefax Group (at least 1 which shouldn't be ignored) , and understanding these should be part of your investment process.
Future Earnings: How does CFX's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the AIM every day. If you want to find the calculation for other stocks just search here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Lemonade First Quarter 2025 Earnings: Beats Expectations
Revenue: US$151.2m (up 27% from 1Q 2024). Net loss: US$62.4m (loss widened by 32% from 1Q 2024). US$0.86 loss per share (further deteriorated from US$0.67 loss in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 7.5%. Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's shares are up 4.6% from a week ago. You should always think about risks. Case in point, we've spotted 3 warning signs for Lemonade you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Yahoo
Salesforce (NYSE:CRM) Declares Quarterly Dividend of US$0.42 Per Share
Salesforce recently affirmed a quarterly cash dividend of $0.42 per share, payable in July 2025. Over the last week, Salesforce's share price remained flat, mirroring the overall market's stable performance despite the broader market experiencing gains, particularly in tech stocks. The market showed resilience with the S&P 500 reaching 6,000 points, bolstered by solid economic data such as the May jobs report. Salesforce's dividend announcement aligns with these broader market sentiments but didn't significantly influence its stock price, reflecting the prevailing investor confidence in robust economic conditions. We've discovered 1 warning sign for Salesforce that you should be aware of before investing here. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent dividend announcement by Salesforce anchors its long-term strategy to retain investor confidence, reflecting robust economic expectations. Over five years, Salesforce's total return—including share price and dividends—was 56.38%, offering a valuable context to its stable performance over the last week. While the company's share price mirrored a flat overall market recently, it indicates that investors may have already priced in the anticipated market resilience and economic growth. Salesforce's shares did underperform the broader US Software industry over the past year, which experienced a higher return of 21.9% compared to the market's 11%. The dividend news alone may not significantly shift revenue and earnings forecasts but underscores the company's commitment to shareholders amidst economic optimism. Analysts forecast Salesforce's revenue to grow by 9% annually over the next three years, with earnings projected to reach US$9.9 billion by 2028. The share price reveals a 32.6% discount compared to the consensus price target of US$354.14, suggesting potential for appreciation if these forecasts are realized. The company's strengthening of AI and data initiatives through investments like Agentforce and Data Cloud may provide further revenue streams, potentially impacting long-term share performance positively. However, risks such as pricing model transitions and external competition remain considerations for Salesforce's future growth trajectory. Click here and access our complete financial health analysis report to understand the dynamics of Salesforce. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CRM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
19 hours ago
- Yahoo
Datadog (NasdaqGS:DDOG) Approves Amendment to Certificate of Incorporation at AGM
Datadog recently approved changes to its Certificate of Incorporation, reflecting a strategic corporate governance update. Over the last month, the company's share price rose by about 15%, aligning with broader market trends where major indexes like the S&P 500 continued to post gains. The strength in overall market sentiment, driven by solid economic data and eased concerns over tariffs, likely provided a favorable backdrop. While the amendments to Datadog's corporate bylaws may have added some weight to investor confidence, the company's price move generally mirrored the robust performance of the tech sector. We've discovered 1 weakness for Datadog that you should be aware of before investing here. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Datadog's recent updates to its Certificate of Incorporation may contribute to an enhanced perception of corporate governance, potentially fostering an environment conducive to increased investor confidence. Aligning with technological advancements, Datadog's robust adoption of AI integrations and strategic acquisitions supports a narrative of growth, especially as these initiatives align with buoyant market conditions. As total shareholder returns indicate, Datadog's shares delivered a substantial 55.99% return over a five-year period. However, amid the past year's 11% performance that matched the broader U.S. market, the company's longer-term trajectory remains significant for current and prospective stakeholders. Despite the optimism surrounding its product innovations and acquisitions, the company's share price movement in relation to the consensus price target suggests a broader context of challenges and expectations. Currently trading at US$118.66, the share price remains approximately 12.5% below the consensus analyst price target of US$135.55, highlighting both growth potential and market skepticism. The news and corporate actions reinforce potential pathways for increased revenue and profitability, where forecasts anticipate revenue growth to US$4.90 billion within three years. However, expected earnings growth juxtaposes potential financial pressures from increased costs and international market expansion, underscoring an essential balance in achieving projected outcomes. Insights from our recent valuation report point to the potential undervaluation of Datadog shares in the market. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:DDOG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio